Vigil Neuro
Ryan O'Mara is an experienced clinical operations professional currently serving as the Sr Director of Clinical Operations and Trial Innovations at Vigil Neuroscience since January 2021. Prior to this role, Ryan held the position of Director of Clinical Operations and Trial Innovations at the same company. Before joining Vigil Neuroscience, Ryan worked at Sarepta Therapeutics as the Associate Director of Clinical Performance Management and Effectiveness from December 2018 to January 2021. Additional experience includes serving as Sr Manager of Clinical Operations at Cavion, Inc. and as Clinical Team Leader at INC Research. Ryan's educational background includes studies at SUNY Brockport and the University of Rochester.
This person is not in any offices
Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.